Sorrento Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2015 to 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2015 to 2022.
  • Sorrento Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 551M shares, a 36.9% increase year-over-year.
  • Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 419M shares, a 42.3% increase from 2021.
  • Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 295M shares, a 28.3% increase from 2020.
  • Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 230M shares, a 63.6% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 419M +125M +42.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 295M +65M +28.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 230M +89.3M +63.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 141M +34.4M +32.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 106M +35.8M +50.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 70.4M +20M +39.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 50.4M +13.5M +36.4% Jan 1, 2016 Dec 31, 2016 8-K 2019-06-17
2015 36.9M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.